ZYME - Zymeworks Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.63B
Enterprise Value 31.18B
Trailing P/E N/A
Forward P/E 1-12.95
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)55.29
Price/Book (mrq)5.78
Enterprise Value/Revenue 339.87
Enterprise Value/EBITDA 6-7.94

Trading Information

Stock Price History

Beta (5Y Monthly) 1.49
52-Week Change 3100.19%
S&P500 52-Week Change 3-11.36%
52 Week High 352.75
52 Week Low 314.65
50-Day Moving Average 337.51
200-Day Moving Average 337.46

Share Statistics

Avg Vol (3 month) 3471k
Avg Vol (10 day) 3490.5k
Shares Outstanding 545.53M
Float 39.67M
% Held by Insiders 110.43%
% Held by Institutions 163.90%
Shares Short (Mar 12, 2020) 4590.66k
Short Ratio (Mar 12, 2020) 41.44
Short % of Float (Mar 12, 2020) 41.31%
Short % of Shares Outstanding (Mar 12, 2020) 41.30%
Shares Short (prior month Feb 13, 2020) 4440.73k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Dec 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-510.08%

Management Effectiveness

Return on Assets (ttm)-30.75%
Return on Equity (ttm)-68.25%

Income Statement

Revenue (ttm)29.54M
Revenue Per Share (ttm)0.78
Quarterly Revenue Growth (yoy)-93.50%
Gross Profit (ttm)-86.36M
EBITDA -148.39M
Net Income Avi to Common (ttm)-145.44M
Diluted EPS (ttm)-3.83
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)298.9M
Total Cash Per Share (mrq)6.57
Total Debt (mrq)6.94M
Total Debt/Equity (mrq)2.82
Current Ratio (mrq)3.78
Book Value Per Share (mrq)6.21

Cash Flow Statement

Operating Cash Flow (ttm)-81.85M
Levered Free Cash Flow (ttm)-9.17M